Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hologic hits 52-week high
Yahoo/Investors
Wednesday, January 9, 2013 - 10:52pm
tags:
Hologic, 52 week high, stock
PerkinElmer and Verinata Health Announce Collaboration to Expand Access to Non-Invasive Prenatal Test for Down Syndrome and Other Chromosomal Abnormalities
Yahoo/BusinessWire
Wednesday, January 9, 2013 - 10:26pm
tags:
PerkinElmer, Verinata, Downs Syndrome
Kamada Said to Seek as Much as $50 Million in Nasdaq Listing
Bloomberg
Wednesday, January 9, 2013 - 10:25pm
tags:
Kamada, NASDAQ, stock
Dendreon's Provenge Revenue Trends
Seeking Alpha
Wednesday, January 9, 2013 - 12:20pm
tags:
Dendreon, earnings
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wednesday, January 9, 2013 - 12:20pm
tags:
FDA, drug approvals, Roche, T-DM1, Aveo, Delcath, Navidea Biopharmaceuticals, Lymphoseek, tivozanib, chemostat
Hyperion's Drug Ravicti Likely To Receive FDA Approval
Seeking Alpha
Wednesday, January 9, 2013 - 12:18pm
tags:
Hyperion, Ravicti, FDA, Vertex Pharmaceuticals
A House of Pain for Zogenix
Motley Fool
Wednesday, January 9, 2013 - 12:16pm
tags:
Zogenix, Zohydro ER
First Half Of 2013 To Be A Critical Time For Exact Sciences
Seeking Alpha
Wednesday, January 9, 2013 - 10:10am
tags:
EXACT Sciences, Sequenom, Illumina, Amarantus BioSciences, Cologuard
4 Biotechnology Stocks With Upcoming Catalysts
Seeking Alpha
Wednesday, January 9, 2013 - 10:06am
tags:
Vivus, Peregrine Pharmaceuticals, JNJ, Cellceutix
Vertex Refocuses Drug Development to Specialty Diseases
Bloomberg
Wednesday, January 9, 2013 - 10:03am
tags:
Vertex Pharmaceuticals, JPMHC 2013, Kalydeco, Incivek
JPMorgan Healthcare Conference Highlights: Regeneron Pharmaceuticals
Motley Fool
Wednesday, January 9, 2013 - 10:02am
tags:
Regeneron, JPMHC 2013
JPMorgan Healthcare Conference Highlights: Bristol-Myers Squibb
Motley Fool
Wednesday, January 9, 2013 - 10:01am
tags:
JPMHC 2013, Bristol-Myers Squibb
Will AbbVie's Drug Pipeline Cloud Its Growth Prospects?
Motley Fool
Wednesday, January 9, 2013 - 10:01am
tags:
AbbVie, Abbott, Eli Lilly, Merck, Pfizer
Former Merck Worker: I Was Fired Over My Age
Pharmalot
Wednesday, January 9, 2013 - 9:31am
tags:
Merck, age discrimination
Peregrine Recovers As Phase II Trial Is Salvaged
Seeking Alpha
Wednesday, January 9, 2013 - 9:31am
tags:
Peregrine Pharmaceuticals, bavituximab, non-small cell lung cancer
The Importance of Alimta
Motley Fool
Wednesday, January 9, 2013 - 8:38am
tags:
Alimta, Eli Lilly
Medicines Co near 5-year high after company says anti-clotting drug cangrelor worked in study
Yahoo/AP
Wednesday, January 9, 2013 - 8:36am
tags:
Cangrelor, Medicines Company
Cliff? What Cliff? Pharma Excels Despite Patent Expiries
Motley Fool
Wednesday, January 9, 2013 - 8:03am
tags:
patent cliff, patents, Eli Lilly, Merck, Pfizer, Teva
Amarin Plays To Some Empty Seats at J.P. Morgan Confab
TheStreet.com
Wednesday, January 9, 2013 - 8:00am
tags:
Amarin, JPMHC 2013, Vascepa
Theravance: Tempting To Investors As Well As Partners
Seeking Alpha
Wednesday, January 9, 2013 - 7:58am
tags:
GSK, Theravance

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.